Dillard's (DDS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Supplement announces the resignation of Warren A. Stephens from the board, effective April 29, 2025, due to his confirmation as U.S. Ambassador to the U.K.
Stephens' resignation was not due to any disagreement with company operations, policies, or practices.
The board seat vacated by Stephens will remain open until a replacement is elected per company bylaws.
Voting matters and shareholder proposals
Votes for Stephens as a Class B director nominee will be disregarded; all other votes will be tabulated as instructed.
Stockholders may change or revoke their votes following procedures in the proxy statement.
Board recommends voting "FOR" the five Class A and nine remaining Class B director nominees.
Board of directors and corporate governance
Warren A. Stephens, a board member since 2002, resigned and will not stand for re-election at the 2025 annual meeting.
No substitute nominee has been designated for Stephens; the board seat will remain vacant until filled according to bylaws.
Latest events from Dillard's
- Merger approved with no shareholder dilution, maintaining governance and proportional ownership.DDS
Proxy filing20 Mar 2026 - Stable annual results with strong cash position and record dividend, despite Q4 sales dip.DDS
Q4 202624 Feb 2026 - Retail sales and net income rose 3% in Q3, with strong cash flow and a $30 special dividend.DDS
Q3 20255 Dec 2025 - Shareholders are voting on reincorporation to Texas, aiming for legal, tax, and governance benefits.DDS
Proxy Filing2 Dec 2025 - 2025 proxy covers director elections, auditor ratification, pay-for-performance, and governance.DDS
Proxy Filing2 Dec 2025 - Proposal seeks shareholder approval to reincorporate from Delaware to Texas, preserving rights and reducing risk.DDS
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the May 2025 annual meeting agenda.DDS
Proxy Filing2 Dec 2025 - Q2 2025 retail sales rose 1% with strong cash flow, stable EPS, and ongoing share repurchases.DDS
Q2 20255 Sep 2025 - Net income and sales fell, but gross margin stayed strong and a $25 dividend was declared.DDS
Q3 202413 Jun 2025